Koyfin Home > Directory > Health Care > Apellis Pharmaceuticals Inc > Return on Equity %

Apellis Pharmaceuticals Inc Return on Equity % Chart (APLS)

Apellis Pharmaceuticals Inc annual/quarterly Return on Equity % from 2017 to 2018.
  • Apellis Pharmaceuticals Inc Return on Equity % for the quarter ending September 09, 2018 was -67.63 a -34.01% increase of 23.00 year over year
  • Apellis Pharmaceuticals Inc Return on Equity % for the last 12 months ending September 09, 2018 was -105.01 a 43.76% decrease of -45.96 year over year
  • Apellis Pharmaceuticals Inc Annual Return on Equity % for 2017 was -59.06 a -56.30% increase of 33.25 from 2016
  • Apellis Pharmaceuticals Inc Annual Return on Equity % for 2016 was -92.31 a -109.09% increase of 100.70 from 2015
  • Apellis Pharmaceuticals Inc Annual Return on Equity % for 2015 was -193.01
Other Margins & Efficiency Metrics:
  • Apellis Pharmaceuticals Inc Return on Capital % for the quarter ending September 09, 2018 was -37.36 a -28.40% increase of 10.61 year over year
View Chart On Koyfin

Quarterly APLS Return on Equity % Data

09/2018-67.63
06/2018-74.37
03/2018-62.55
12/2017-90.63
09/2017-596.19
06/2017-357.70

Annual APLS Return on Equity % Data

2017-59.06
2016-92.31
2015-193.01